Reports from Tisch Cancer Institute Describe Recent Advances in Metastatic Breast Cancer (Results of a Phase Ib Study Investigating Durvalumab In Combination With Eribulin In Patients With Her2-negative Metastatic Breast Cancer and Recurrent ...)

  • Meng Ru

Press/Media

Period22 Sep 2023

Media coverage

1

Media coverage

  • TitleReports from Tisch Cancer Institute Describe Recent Advances in Metastatic Breast Cancer (Results of a Phase Ib Study Investigating Durvalumab In Combination With Eribulin In Patients With Her2-negative Metastatic Breast Cancer and Recurrent ...)
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date22/09/23
    PersonsMeng Ru
View all 1
View less

Related content